Sign up to save your podcasts
Or
Share Pfizer-BioNTech Covid vaccine for 5 to 11-year-olds; Salesforce invests in Razorpay; and a chat with SatSearch’s COO Narayan Prasad
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pfizer-BioNTech Covid vaccine for 5 to 11-year-olds; Salesforce invests in Razorpay; and a chat with SatSearch’s COO Narayan Prasad
Pfizer and BioNTech have said that the first test results of their Covid-19 vaccine tested on children, age group of 5 to 11 years, showed the vaccine to be effective. The Covid-19 vaccine was well tolerated, with side effects generally comparable to those observed in participants in the age group of 16 years to 25 years, the companies said in a press release. In our tech conversation today, Narayan Prasad Nagendra, COO of SatSearch, explains the new space tech opportunities for Indian companies
View all episodes
By One Thing Today in Tech
1
11 ratings
Pfizer and BioNTech have said that the first test results of their Covid-19 vaccine tested on children, age group of 5 to 11 years, showed the vaccine to be effective. The Covid-19 vaccine was well tolerated, with side effects generally comparable to those observed in participants in the age group of 16 years to 25 years, the companies said in a press release. In our tech conversation today, Narayan Prasad Nagendra, COO of SatSearch, explains the new space tech opportunities for Indian companies